4.6 Article

Effect of Ischemia Duration and Door-to-Balloon Time on Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction An Analysis From HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction)

Journal

JACC-CARDIOVASCULAR INTERVENTIONS
Volume 8, Issue 15, Pages 1966-1974

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcin.2015.08.031

Keywords

ischemia duration; myocardial infarction; PCI; perfusion; STEMI

Funding

  1. Medicines Company
  2. Bristol-Myers Squibb/Sanofi
  3. Eli Lilly
  4. Company/Daiichi-Sankyo
  5. Regado Biosciences
  6. AstraZeneca
  7. STENTYS
  8. Abbott Vascular
  9. Boston Scientific
  10. St. Jude Medical
  11. Abbott
  12. Adamed
  13. Adyton Medical Polska
  14. Abiomed Europe
  15. Biotronik
  16. Balton
  17. Bayer
  18. B. Braun
  19. BioMatrix
  20. Boehringer Ingelheim
  21. Bracco
  22. Bristol-Myers Squibb
  23. Comesa Polska
  24. Cordis
  25. Cook
  26. Covidien Polska Sp. z o. o.
  27. DRG MedTek
  28. EuroCor
  29. Hammermed
  30. GE Healthcare
  31. Glaxo
  32. InspireMD
  33. Iroko Cardio International
  34. Medianet Sp. z o.o.
  35. Medtronic
  36. Meril Life Sciences
  37. Merck Sharp Dohme
  38. Orbus-Neich
  39. Pfizer
  40. Possis
  41. ProCardia Medical
  42. Promed
  43. REVA Medical
  44. Sanofi-Aventis
  45. Siemens
  46. Solvay
  47. Terumo
  48. Tyco
  49. Volcano
  50. Elixir Medical
  51. Atrium Medical

Ask authors/readers for more resources

OBJECTIVES This study sought to investigate the effect of treatment delay on microvascular reperfusion in ST-segment elevation myocardial infarction (STEMI) patients from the large, multicenter, prospective HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial. BACKGROUND Despite restoration of epicardial blood flow during primary percutaneous coronary intervention (PCI), one-third of patients do not obtain myocardial perfusion due to impairment in the microvascular circulation. METHODS We examined the effect of symptom onset-to-balloon time (SBT) and door-to-balloon time (DBT) on myocardial reperfusion during primary PCI in STEMI, utilizing resolution of ST-segment elevation (STR) and the myocardial blush grade (MBG). The primary analysis was the relationships between SBT <= 2, >2 to 4, and >4h and DBT <= 1, >1 to 1.5, >1.5 to 2, and >2 h with MBG and STR. Clinical risk was assessed using a modified version of the Thrombolysis In Myocardial Infarction risk score for STEMI. RESULTS In 2,056 patients, absent microvascular perfusion (MBG 0/1) and STR (STR <30%) after primary PCI was significantly more common in patients with longer SBT, in patients with both low and high clinical risk profiles. By multivariable analysis, SBT (p < 0.0001), anterior infarction (p < 0.0001), reference vessel diameter (p - 0.005), lesion minimum lumen diameter (p < 0.0001), hyperlipidemia (p = 0.03), and current smoking (p = 0.001) were independent predictors of MBG 0/1, whereas SBT (p = 0.007), anterior infarction (p < 0.0001), and history of renal insufficiency (p = 0.0002) were independent predictors of absent STR. DBT (p < 0.0001) was an independent predictor of MBG 0/1. MBG 0/1 and STR <30% identified patients with increased 3-year mortality. CONCLUSIONS The present study suggests that delay in mechanical reperfusion therapy during STEMI is associated with greater injury to the microcirculation. (C) 2015 by the American College of Cardiology Foundation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available